Showing all 7 results

Showing all 7 results

Category
    ANIMALS

      Brovmast 2D, syringe for Cattle 40 ml

      Original price was: $60.38.Current price is: $41.68.
      2D Brovamast Antimastitis Drugs (cloxacillin, neomycin, sulfathiazole) 10 ml *4 pcs Treatment of cows in lactation acute and subacute forms

      Brovmast C syringe for Cattle, 5 ml

      Original price was: $26.40.Current price is: $21.88.
      Prevention of dry cows with subclinical and clinical mastitis. The syringe-5 ml tube.

      Solution for cows (mastitis treatment) – 10 pcs

      $43.88

      Bayoclox Bayer (Dariclox analog) (Cloxacillin)

      Bayoclox DC is an antibacterial drug containing 11.11% cloxacillin (in the form of a salt of benzathic acid) as an active ingredient, as well as form-forming components (aluminum stearate and liquid paraffin).

      In appearance, the drug is a homogeneous suspension of a grayish-white color.

      Bayoclox DC is released in the form of a sterile suspension, packaged in 4.5 g in plastic injectors.

      Each injector contains 500 mg of cloxacillin.

      Brovmast 2D syringe for Cattle 10 ml

      Original price was: $26.40.Current price is: $20.90.
      Treatment of dairy cows with serous, catarrhal, fibrinous, purulent, subclinical mastitis. The syringe-tube 10 ml.

      Brovmast C syringe for Cattle, 20 ml

      Original price was: $59.40.Current price is: $43.88.
      Brovmast C (cloxacilin benzathine – 600 mg), 20 ml (5 ml * 4 pcs) Cloxacillin benzathine is a synthetic compound

      Brovmast 1D, 100 ml for Cattle

      $28.60
      Treatment of cows in lactation acute and subacute forms of bacterial etiology of mastitis. 100 ml bottle.

      Brovmast 2D, 100 ml for Cattle

      $28.60
      Treatment of dairy cows with serous, catarrhal, fibrinous, purulent, subclinical mastitis. 100 ml bottle.

      Antibiotics & Pharmacy Livestock

      The use of antibiotics in animal husbandry is the use of antibiotics for any purpose, in animal husbandry from livestock, which includes treatment in case of illness ( therapeutic ), treatment of a group of animals when at least one is diagnosed with a clinical infection (metaphylaxis), and preventive treatment ( prevention). Antibiotics are an important tool for treating animal and human diseases, protecting animal health and welfare, and ensuring food safety. However, if used irresponsibly, this can lead to antibiotic resistance, which can affect human, animal, and environmental health. Although levels of use vary greatly from country to country, for example, in some Northern European countries very low amounts are used to treat animals compared to humans, worldwide, it is estimated that 73% of antimicrobials (mainly antibiotics) are consumed by farm animals. In addition, a 2015 study also estimates that global use of agricultural antibiotics will increase by 67% from 2010 to 2030, mainly due to increased use in developing BRIC countries. This is a concern because antibiotic resistance is considered a serious threat to human and animal welfare in the future, and rising levels of antibiotics or antibiotic-resistant bacteria in the environment may lead to an increase in drug-resistant infections in both cases. Infectious diseases are the third leading cause of death in Europe, and a future without effective antibiotics will fundamentally change the methods of modern medicine and veterinary medicine. However, laws and other restrictions on the use of antibiotics in farm animals are currently being introduced around the world. In 2017, the world health organization strongly recommended reducing the use of antibiotics in animals used in the food industry. The use of antibiotics to promote growth has been banned in the European Union since 2006, and the use of sub-therapeutic doses of medically important antibiotics in animal feed and water to promote growth and improve feed efficiency has been illegal in the United States since January 1. In 2017, through a change in legislation passed by the food and drug administration (FDA), which sought voluntary consent from drug manufacturers to re-label their antibiotics.